Marco Ranzani

2.5k total citations
13 papers, 1.1k citations indexed

About

Marco Ranzani is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Marco Ranzani has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Marco Ranzani's work include Virus-based gene therapy research (6 papers), RNA Interference and Gene Delivery (4 papers) and CRISPR and Genetic Engineering (2 papers). Marco Ranzani is often cited by papers focused on Virus-based gene therapy research (6 papers), RNA Interference and Gene Delivery (4 papers) and CRISPR and Genetic Engineering (2 papers). Marco Ranzani collaborates with scholars based in Italy, United Kingdom and Germany. Marco Ranzani's co-authors include Eugenio Montini, Luigi Naldini, Fabrizio Benedicenti, Manfred Schmidt, Daniela Cesana, Christof von Kalle, Lucia Sergi Sergi, Claudio Doglioni, Francesca Sanvito and Cynthia C. Bartholomae and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Nature Methods.

In The Last Decade

Marco Ranzani

13 papers receiving 1.1k citations

Peers

Countries citing papers authored by Marco Ranzani

Since Specialization

Citations

This map shows the geographic impact of Marco Ranzani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Ranzani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Ranzani more than expected).

Fields of papers citing papers by Marco Ranzani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Ranzani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Ranzani. The network helps show where Marco Ranzani may publish in the future.

Co-authorship network of co-authors of Marco Ranzani

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Ranzani. A scholar is included among the top collaborators of Marco Ranzani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Ranzani. Marco Ranzani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Abstract 1341: A novel ATR inhibitor combined with radiation sensitizes an immunologically cold tumor to immunotherapy 2025 ·Cancer Research ·(unknown), Scott J. Bright, Poliana Camila Marinello, Jayesh B. Majithiya, (unknown), Marco Ranzani, Helen M. Robinson, Graeme C.M. Smith, Gabriel O. Sawakuchi	1
2	139 (PB127): ART6043: a first-in-class clinical DNA Polymerase Theta polymerase domain inhibitor for potentiating PARP inhibitor efficacy 2024 ·European Journal of Cancer ·(unknown), (unknown), S. Holt, Jayesh B. Majithiya, Claire McWhirter, (unknown), Marco Ranzani, (unknown), Paula Costales, Elias Elinati, Alessandro Galbiati, Ana Toste Rêgo, Macarthur Charles, Harry Finch, Geoff S. Higgins, Simon J. Boulton, (unknown), George M. Langford, Niall M.B. Martin, Graeme C.M. Smith	1
3	Supporting Job Search for Mauritian Youth with Little Education 2020 ·World Bank, Washington, DC eBooks ·(unknown), Isis Gaddis, Marco Ranzani, (unknown)	1
4	ALDH1 Bio-activates Nifuroxazide to Eradicate ALDHHigh Melanoma-Initiating Cells 2018 ·Cell chemical biology ·(unknown), (unknown), Yuting Lu, Li‐Fan Zeng, Thomas D. Hurley, Douglas R. Houston, Alex von Kriegsheim, Che‐Hong Chen, Daria Mochly‐Rosen, Marco Ranzani, Marie E. Mathers, Xiaowei Xu, Wei Xu, David J. Adams, Neil O. Carragher, Mayumi Fujita, Lynn M. Schuchter, Asier Unciti‐Broceta, Valerie G. Brunton, E. Elizabeth Patton	47
5	Synthetic lethality: emerging targets and opportunities in melanoma 2017 ·Pigment Cell & Melanoma Research ·Nicola Thompson, David J. Adams, Marco Ranzani	12
6	CopywriteR: DNA copy number detection from off-target sequence data 2015 ·Genome Biology ·Thomas Kuilman, Arno Velds, Kristel Kemper, Marco Ranzani, Lorenzo Bombardelli, Marlous Hoogstraat, Ekaterina Nevedomskaya, Guotai Xu, Julian de Ruiter, Martijn P. Lolkema, Bauke Ylstra, Jos Jonkers, Sven Rottenberg, Lodewyk F.A. Wessels, David J. Adams, Daniel S. Peeper, Oscar Krijgsman	119
7	Uncovering and Dissecting the Genotoxicity of Self-inactivating Lentiviral Vectors In Vivo 2014 ·Molecular Therapy ·Daniela Cesana, Marco Ranzani, Monica Volpin, Cynthia C. Bartholomae, (unknown), (unknown), Stefania Merella, Fabrizio Benedicenti, Lucia Sergi Sergi, Francesca Sanvito, Chiara Brombin, Alessandro Nonis, Clelia Di Serio, Claudio Doglioni, Christof von Kalle, Manfred Schmidt, Odile Cohen‐Haguenauer, Luigi Naldini, Eugenio Montini	148
8	Lentiviral Vector-based Insertional Mutagenesis Identifies Genes Involved in the Resistance to Targeted Anticancer Therapies 2014 ·Molecular Therapy ·Marco Ranzani, Stefano Annunziato, Andrea Calabria, (unknown), Fabrizio Benedicenti, Pierangela Gallina, Luigi Naldini, Eugenio Montini	14
9	Lentiviral vector–based insertional mutagenesis identifies genes associated with liver cancer 2013 ·Nature Methods ·Marco Ranzani, Daniela Cesana, Cynthia C. Bartholomae, Francesca Sanvito, Mauro Pala, Fabrizio Benedicenti, Pierangela Gallina, Lucia Sergi Sergi, Stefania Merella, Alessandro Bulfone, Claudio Doglioni, Christof von Kalle, Yoon Jun Kim, Manfred Schmidt, Giovanni Tonon, Luigi Naldini, Eugenio Montini	78
10	Cancer Gene Discovery: Exploiting Insertional Mutagenesis 2013 ·Molecular Cancer Research ·Marco Ranzani, Stefano Annunziato, David J. Adams, Eugenio Montini	60
11	Notch1 regulates chemotaxis and proliferation by controlling the CC‐chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia 2011 ·The Journal of Pathology ·Leonardo Mirandola, Maurizio Chiriva‐Internati, Daniela Montagna, Franco Locatelli, Marco Zecca, Marco Ranzani, Andrea Basile, Massimo Locati, Everardo Cobos, W. Martin Kast, Rosanna Asselta, Elvezia Maria Paraboschi, Paola Comi, Raffaella Chiaramonte	51
12	Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection 2011 ·Blood ·Alessandra Biffi, (unknown), Daniela Cesana, Nathalie Cartier, (unknown), Marco Ranzani, Martina Cesani, Fabrizio Benedicenti, Tiziana Plati, Enrico Rubagotti, Stefania Merella, Alessia Capotondo, (unknown), Gianluigi Zanetti, Christof von Kalle, Manfred Schmidt, Luigi Naldini, Eugenio Montini	173
13	The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy 2009 ·Journal of Clinical Investigation ·Eugenio Montini, Daniela Cesana, Manfred Schmidt, Francesca Sanvito, Cynthia C. Bartholomae, Marco Ranzani, Fabrizio Benedicenti, Lucia Sergi Sergi, Alessandro Ambrosi, Maurilio Ponzoni, Claudio Doglioni, Clelia Di Serio, Christof von Kalle, Luigi Naldini	413

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact